Evaluation of the immunomodulatory effects of anti-COVID-19 TCM formulae by multiple virus-related pathways

Liansheng Qiao; Wenting Huang; Xiaoling Zhang; Hongyan Guo; Dong Wang; Quansheng Feng; Ronghua Jin; Lan Xie; Weimin Li; Jing Cheng

doi:10.1038/s41392-021-00475-w

Evaluation of the immunomodulatory effects of anti-COVID-19 TCM formulae by multiple virus-related pathways

Signal Transduct Target Ther. 2021 Feb 4;6(1):50. doi: 10.1038/s41392-021-00475-w.

Authors

Liansheng Qiao^#^{1

2

3}, Wenting Huang^#^{1

2

3}, Xiaoling Zhang⁴, Hongyan Guo⁴, Dong Wang⁵, Quansheng Feng⁵, Ronghua Jin⁶, Lan Xie^{7

8

9

10}, Weimin Li¹¹, Jing Cheng^{12

13

14

15

16}

Affiliations

¹ State Key Laboratory of Membrane Biology, School of Medicine, Tsinghua University, Beijing, 100084, China.
² Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, 310003, China.
³ Medical Systems Biology Research Center, School of Medicine, Tsinghua University, Beijing, 100084, China.
⁴ National Engineering Research Center for Beijing Biochip Technology, Beijing, 102206, China.
⁵ School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
⁶ Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China.
⁷ State Key Laboratory of Membrane Biology, School of Medicine, Tsinghua University, Beijing, 100084, China. xielan@tsinghua.edu.cn.
⁸ Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, 310003, China. xielan@tsinghua.edu.cn.
⁹ Medical Systems Biology Research Center, School of Medicine, Tsinghua University, Beijing, 100084, China. xielan@tsinghua.edu.cn.
¹⁰ National Engineering Research Center for Beijing Biochip Technology, Beijing, 102206, China. xielan@tsinghua.edu.cn.
¹¹ Department of Respiratory and Critic Care Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China. weimin003@163.com.
¹² State Key Laboratory of Membrane Biology, School of Medicine, Tsinghua University, Beijing, 100084, China. jcheng@tsinghua.edu.cn.
¹³ Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, 310003, China. jcheng@tsinghua.edu.cn.
¹⁴ Medical Systems Biology Research Center, School of Medicine, Tsinghua University, Beijing, 100084, China. jcheng@tsinghua.edu.cn.
¹⁵ National Engineering Research Center for Beijing Biochip Technology, Beijing, 102206, China. jcheng@tsinghua.edu.cn.
¹⁶ School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China. jcheng@tsinghua.edu.cn.

^# Contributed equally.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

COVID-19 Drug Treatment*
COVID-19* / genetics
COVID-19* / metabolism
Drug Evaluation, Preclinical
Drugs, Chinese Herbal / pharmacology*
Humans
Immunologic Factors / pharmacology*
Medicine, Chinese Traditional*

Substances

Drugs, Chinese Herbal
Immunologic Factors